I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., [(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis., Journal of Nuclear Medicine, ISSN:1535-5667
et al., 2018, The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis., Neurology
et al., 2018, Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis., Mult Scler
et al., 2017, C-11-PBR28 and F-18-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis, Journal of Nuclear Medicine, Vol:58, ISSN:0161-5505, Pages:1477-1482
et al., 2017, Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial, Lancet Neurology, Vol:16, ISSN:1474-4422, Pages:591-600